Article info
PDFReview
A double-edged sword: does highly active antiretroviral therapy contribute to syphilis incidence by impairing immunity to Treponema pallidum?
- Correspondence to Dr Michael L Rekart, School of Population and Public Health, University of British Columbia, 2206 East Mall, Rm. 147, Vancouver, BC, Canada V6T 1Z3; Michael.rekart{at}gmail.com
Citation
A double-edged sword: does highly active antiretroviral therapy contribute to syphilis incidence by impairing immunity to Treponema pallidum?
Publication history
- Received August 28, 2016
- Revised October 17, 2016
- Accepted October 29, 2016
- First published January 16, 2017.
Online issue publication
June 29, 2021
Article Versions
- Previous version (29 June 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/